leukapheresis


Also found in: Medical, Wikipedia.
Translations

leuk·a·phe·re·sis

n. leucaferesis, separación de leucocitos de la sangre de un paciente con subsecuente retransfusión al mismo paciente.
References in periodicals archive ?
Patients eligible for randomization and treatment will be those (1) who have undergone debulking surgery, (2) for whom a cell line has been established, (3) who have undergone leukapheresis from which sufficient monocytes were obtained, (4) have an ECOG performance grade of 0 or 1 (Karnofsky score of 70-100%), and (5) who have completed primary therapy.
Daily peripheral blood CD34+ cells counts were measured, and leukapheresis was carried out when peripheral blood CD34+ cell counts were more than 20 cells/[micro]L.
According to the company, the X-LAB device isolates and purifies target cell fractions from blood, bone marrow or leukapheresis in a "closed system," with precision and high efficiency.
For the peripheral blood stem cell (G-PB) collection, leukapheresis was commenced on the 5th day after G-CSF conditioning using a COBE Spectra (Spectra LRS; COBE BCT Inc., Lakewood, CO, USA) at a planned rate of 80 ml/min.
[USPRwire, Tue Sep 18 2018] According to a new market research report "Leukapheresis Market by Product (Apheresis Machine, Leukocyte Filter, Column, Disposables), Leukopak (Mobilized, Non-Mobilized, Human Primary Cells), Application (Research, Therapeutic), End User (Hospitals, Research Institute)Ce--CeGlobal Forecast to 2023", published by MarketsandMarketsao.
They are all currently autologous --that is white cells are harvested from the patient by Leukapheresis, sent to a central facility, genetically transformed by virus and, after extensive QC, sent back for infusion into the patient.
GMA was performed using the Adacolumn[R] leukapheresis system (Otsuka Pharmaceuticals, Tokyo, Japan).
Serafini et al., "Large volume leukapheresis for collecting hemopoietic progenitors: Role of CD 34+ precount in predicting successful collection," The International Journal of Artificial Organs, vol.
Various other therapies including hydroxyurea, interferon, various combinations of chemotherapeutic agents, and intensive leukapheresis have been suggested to lower the risk of progression, induce rapid disease control, or possibly reverse the blastic stage for those who are unable or unwilling to continue with TKI therapy, but these have not been validated [16,17].